Insight Molecular Diagnostics Inc. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Insight Molecular Diagnostics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2026-06-30 was $8.00K.
- Insight Molecular Diagnostics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2026-03-31 was $24.00K.
- Insight Molecular Diagnostics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-12-31 was $24.00K.
- Insight Molecular Diagnostics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2024-12-31 was $0.00.
- Insight Molecular Diagnostics Inc. stock issued during period, value, restricted stock award, gross for fiscal 2025 was $40.00K, a 44.44% decline from fiscal 2024.
- Insight Molecular Diagnostics Inc. stock issued during period, value, restricted stock award, gross for fiscal 2024 was $72.00K, a 100.00% increase from fiscal 2023.
- Insight Molecular Diagnostics Inc. stock issued during period, value, restricted stock award, gross for fiscal 2023 was $36.00K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2026-06-30 | $8.00K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $24.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $40.00K 10-K · filed 2026-03-26 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $72.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $72.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $36.00K 10-Q · filed 2025-08-11 | $108.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $36.00K 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $36.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $36.00K 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |